ANDA 88771, held by Caplin Steriles. Dexamethasone Sodium Phosphate.
As of Nov 21, 2026, ANDA 88771 (Dexamethasone Sodium Phosphate), held by Caplin Steriles, was first approved by FDA on Jan 16, 1985, with 18 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 16, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dexamethasone Sodium PhosphateEQ 0.1% PHOSPHATE · solution/drops;ophthalmic, otic | Dexamethasone Sodium Phosphate | Discontinued |
| Mar 6, 2009 | Supplement 24Labeling | Approved | None posted |
| Apr 11, 2005 | Supplement 22Labeling | Approved | None posted |
| May 10, 1999 | Supplement 17Manufacturing | Approved | None posted |
| Feb 19, 1999 | Supplement 15Manufacturing | Approved | None posted |
| Feb 2, 1999 | Supplement 14Manufacturing | Approved | None posted |
| Jul 29, 1997 | Supplement 13Manufacturing | Approved | None posted |
| Dec 4, 1996 | Supplement 12Manufacturing | Approved | None posted |
| Apr 16, 1996 | Supplement 10Manufacturing | Approved | None posted |
| Dec 15, 1995 | Supplement 11Manufacturing | Approved | None posted |
| Jan 26, 1995 | Supplement 9Labeling | Approved | None posted |
| Feb 8, 1994 | Supplement 8Labeling | Approved | None posted |
| Feb 8, 1994 | Supplement 7Labeling | Approved | None posted |
| Sep 19, 1991 | Supplement 29Labeling | Approved | None posted |
| Sep 19, 1991 | Supplement 6Labeling | Approved | None posted |
| Aug 3, 1988 | Supplement 5Manufacturing | Approved | None posted |
| Aug 3, 1988 | Supplement 4Manufacturing | Approved | None posted |
| Oct 14, 1986 | Supplement 2Manufacturing | Approved | None posted |
| May 2, 1986 | Supplement 1Manufacturing | Approved | None posted |
| Jan 16, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters